YD Bio Limited (“YD Bio” or the “Company”) (NasdaqGM: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today rang the Opening ...
An update from Inoviq Ltd ( (AU:IIQ) ) is now available.
Inoviq Ltd ( ($AU:IIQ) ) has issued an update. INOVIQ Ltd has announced a capital raise to support its ongoing development in the field of ...
Inoviq Ltd ( ($AU:IIQ) ) has provided an announcement. INOVIQ Ltd has appointed Peter Gunzburg as a Non-Executive Director, effective October 20, ...
YD Bio business partner, EG Biomed achieves CAP accreditation, advancing US clinical testing capabilities: Taipei, Taiwan Monday, October 13, 2025, 17:00 Hrs [IST] YD Bio Limited ...
Pakistan must rapidly localise drug development and cut reliance on imported pharmaceutical ingredients to secure its healthcare future, the participants of the International Symposium on Natural ...
Cost of revenue declined by $20,668, or 13%, to $135,212 for the six months ended June 30, 2025, from $155,880 a year earlier, reflecting primarily the 9% drop in net revenue. Cost of revenue consists ...
Press ReleaseEVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseasesThrough this funding round, ...
The skincare ingredient du jour isn't an acid or an oil—but something entirely different. Exosomes may sound like they came out of a sci-fi novel, but they're actually something found naturally within ...
Bio-Techne (TECH) made headlines by announcing an expanded partnership with Oxford Nanopore Technologies. This move extends their collaboration through 2032 and empowers Bio-Techne to broaden its ...